- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
Synonyms: RG 6100; RO7105705; MTAU-9937A
Semorinemab (Anti-Tau) is a humanized IgG4 monoclonal antibody that targets the N-terminal domain of tau (amino acid residues 6-23). Semorinemab has the potential to be used in research on Alzheimer's disease. MW : 150 kD.
| Name | Citation | Microtubule Associated | Microtubule Associated | Others |
|---|---|---|---|---|
| Patupilone (Epothilone B) | 17 | |||
| Plinabulin | 5 | |||
| Lexibulin (CYT997) | 8 | |||
| Epothilone A | 6 | |||
| CW069 | 8 | |||
| RMC-4630 | 0 | |||
| Parbendazole | 0 | |||
| Combretastatin A4 | 7 | |||
| CK-636 | 5 | |||
| ABT-751 (E7010) | 5 | |||
| Nocodazole | 130 | Abl,Abl (E255K),Abl (T315I) | ||
| T-1101 tosylate | 0 | |||
| iHAP1 | 1 | |||
| Trigonelline | 3 | Akt,PI3K,PLCγ1 | ||
| Myoseverin | 0 | |||
| Indibulin | 1 | |||
| EGFR Inhibitor | 3 | EGFR | ||
| MMAF | 1 | |||
| DM1 (Mertansine) | 1 | |||
| SSE15206 | 0 | |||
| ELR-510444 | 0 | |||
| TAI-1 | 2 | |||
| INH6 | 0 | |||
| INH1 | 2 |
| Description |
Semorinemab (Anti-Tau) is a humanized IgG4 monoclonal antibody that targets the N-terminal domain of tau (amino acid residues 6-23). Semorinemab has the potential to be used in research on Alzheimer's disease. MW : 150 kD.
|
References |
|---|
| CAS No. | 2159141-27-0 |
|---|---|
| Molecular Weight | 150 |
| Isotype | Human IgG4SP |
| Source | CHO |
| Purification | AKTA |
| Sterility | 0.2 μM filtered |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.